MARC

LEADER 00000cam a2200000Mi 4500
001 ocn923263435
003 OCoLC
005 20240623213015.0
006 m o d
007 cr |n|||||||||
008 151010s1998 dcu o 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d MERUC  |d OCLCQ  |d XFH  |d OCLCF  |d OCLCO  |d ZCU  |d OCLCO  |d AGLDB  |d OCLCA  |d OCLCQ  |d OCLCO  |d OCLCQ  |d ICG  |d OCLCQ  |d LVT  |d DKC  |d OCLCQ  |d OCLCO  |d UKAHL  |d OCLCQ  |d OCLCA  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL 
019 |a 994606543 
020 |a 9780309591539 
020 |a 0309591538 
020 |a 0309059852 
020 |a 9780309059855 
035 |a (OCoLC)923263435  |z (OCoLC)994606543 
050 4 |a RG133.A2.C67 1998eb 
049 |a HCDD 
100 1 |a Staff, Institute of Medicine. 
245 1 0 |a Contraceptive Research, Introduction and Use :  |b Lessons from Norplant. 
260 |a Washington :  |b National Academies Press,  |c 1998. 
300 |a 1 online resource (128 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a Contraceptive Research, Introduction, and Use -- Copyright -- Acknowledgments -- Contents -- 1 Introduction -- 2 Workshop Report -- EFFICACY AND SAFETY -- Efficacy -- Safety -- Major Health-Related Events -- Significant Health-Related Problems -- Silicone Biocompatibility -- Progestin Effects on Vaginal HIV Transmission -- WHO USES NORPLANT AND HOW -- User Populations -- Method Continuation and Discontinuation -- Side Effects as Factors -- User Satisfaction -- Barriers to Discontinuation -- Cost and Cost-Effectiveness 
505 8 |a Effects of Media Coverage and Litigation on Norplant UseINSERTION AND REMOVAL: EXPERIENCE AND IMPLICATIONS -- Technical Aspects -- Case Experiences -- Rates of Complicated Removals -- Implications -- CONSUMER PERSPECTIVES -- Communication and Quality of Care -- Quality of Care -- Informed Decision-Making -- Importance -- Content -- Special Challenges -- Potential for Abuse -- Consumer Involvement -- NEW APPROACHES -- Reproductive Health Technologies Project's Boom and Bust Initiative -- The WHO Strategic Approach to Contraceptive Introduction 
505 8 |a A ''Government Standards Defense3 Workshop Summary and Analysis -- DATA REVIEW -- Efficacy -- Safety -- User Profiles -- Side Effects -- Continuation and Discontinuation -- User Satisfaction -- Postmarketing Surveillance -- Cost-Effectiveness -- LESSONS LEARNED -- NEXT STEPS: AREAS FOR CONSIDERATION AND ACTION -- Areas for Strengthening or Expansion -- 1. Clinical Research -- 2. Market Research -- 3. Pre-introduction -- 4. Informed Decision-Making -- 5. Postmarketing Surveillance -- Areas for New Initiative -- 6. Credentialing 
505 8 |a 7. Core Guidelines for Long-Acting Contraceptives8. Costs -- 9. Product Liability -- FINAL COMMENT -- ENDNOTES -- Appendixes -- A Presentation Summaries -- Presentation 1 -- Background -- Methodology -- Findings -- Age and Educational Levels -- Major Health-Related Events -- Significant Health-Related Problems -- Continuation and Removals -- Efficacy -- Conclusions -- Presentation 2 -- Background -- Methodology -- Findings -- Pregnancy and Continuation Rates -- Reasons for Discontinuation -- Removal Difficulties 
505 8 |a Mortality and HospitalizationConclusions -- Presentation 3 -- Background -- Methodology -- Findings -- Conclusions -- Presentation 4 -- Background -- Findings -- Composition -- Inflammatory Wound Healing Reaction and Blood Protein Absorption -- Conclusions -- Presentation 5 -- Background -- Methodology -- Findings -- Conclusions -- Presentation 6 -- Background and Methodology -- Findings -- Conclusions -- Presentation 7 -- Background -- Findings -- Conclusions -- Presentation 8 -- Background -- Methodology 
500 |a ""Findings and Conclusions"" 
546 |a English. 
650 0 |a Contraception  |x Research  |v Congresses. 
650 0 |a Contraceptives. 
650 0 |a Reproductive technology. 
650 0 |a Therapeutics. 
650 0 |a Contraception. 
650 0 |a Methodology. 
650 7 |a methodology.  |2 aat 
650 7 |a treating (health care function)  |2 aat 
650 7 |a Therapeutics  |2 fast 
650 7 |a Reproductive technology  |2 fast 
650 7 |a Methodology  |2 fast 
650 7 |a Contraceptives  |2 fast 
650 7 |a Contraception  |2 fast 
650 7 |a Contraception  |x Research  |2 fast 
655 7 |a Conference papers and proceedings  |2 fast 
758 |i has work:  |a Contraceptive research, introduction and use (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGT39HRBWGmpCCRRbpVf7b  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Staff, Institute of Medicine.  |t Contraceptive Research, Introduction and Use : Lessons from Norplant.  |d Washington : National Academies Press, ©1900  |z 9780309059855 
856 4 0 |u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=3376390  |y Click for online access 
903 |a EBC-AC 
994 |a 92  |b HCD